Completed PHASE3 INTERVENTIONAL 2-arm NCT01973400

Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus (VENUS)

A Clinical Study on the Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus

Sponsor: Clinical Research Centre, Malaysia

Conditions Cognitive Impairment Diabetic Neuropathy

Updated 7 times since 2017 Last updated: May 1, 2017 Started: Jun 30, 2011 Primary completion: Sep 30, 2015 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cognitive Impairment and Diabetic Neuropathy and is currently completed. Clinical Research Centre, Malaysia leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
May 2020 — Jan 2021 [monthly]

Completed PHASE3
Jun 2018 — May 2020 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2017 — Jun 2018 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed · Phase: PHASE4 → PHASE3
Jan 2017 — Jun 2017 [monthly]

Active Not Recruiting PHASE4

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinical Research Centre, Malaysia
Malaysia Palm Oil Board
Universiti Sains Malaysia

Data source: Universiti Sains Malaysia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seberang Jaya, Malaysia